CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to advance the use of cyclodextrins in drug formulations by bridging the gap between academic research and clinical application. It focuses on developing new cyclodextrin-based delivery systems and ensuring compliance with production standards for medical use.
Cyclodextrins (CD) have already gained several market applications as excipients in drug and vaccine formulations.
They are very appealing platforms for the development of therapeutic applications and new CD-based systems are continuously proposed.
In this frame easily prepared CD polymers frequently outstand the performance of the corresponding CD monomers.
Nevertheless, application of new CDs as drug or delivery system in the clinics does not take off in spite of their most promising features.…
CONSIGLIO NAZIONALE DELLE RICERCHE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Hungary, Budapest
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Belgium, Leuven
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Türkiye, Cankaya Ankara
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
